FundedIQ
Biotechnology

Nido Biosciences: Funding, Investors & Team (Oct 2026)

Nido Biosciences is a clinical-stage company that develops precision medicines for severe neurological diseases. Nido Bio is developing solutions for severe neurological illnesses based on today's advances in neuroscience. The company creates precise medications using human genetics that treat the underlying biology of disease and restore healthy cell function.

www.nidobio.com Boston, United States 11-50 employees
Total raised
$86.6M
Rounds
1
Latest
Series B
May 2023

Nido Biosciences has raised $86.6M across 1 funding round on record, the most recent a Series B of $86.6M announced in May 2023.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Nido Biosciences Company Profile and Key Stats

Total funding raised
$86.6M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series B
$86.6M in May 2023
Employees
11-50
reported band
Headquarters
Boston, United States

Latest funding round on record: May 2023.

Nido Biosciences Funding Rounds

Date
Round
Amount
Series B
$86.6M

Nido Biosciences Founders and Leadership Team

Name
Role
Contact
Mike Clayman
Founder
—

No contact details are on record for this team yet.

Nido Biosciences Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M
4,422
$32M

Nido Biosciences' latest round of $86.6M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Nido Biosciences in Biotechnology and Boston

Companies Similar to Nido Biosciences

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Nido Biosciences Funding FAQs

What does Nido Biosciences do?

Nido Biosciences is a clinical-stage company that develops precision medicines for severe neurological diseases. Nido Bio is developing solutions for severe neurological illnesses based on today's advances in neuroscience. The company creates precise medications using human genetics that treat the underlying biology of disease and restore healthy cell function.

How much funding has Nido Biosciences raised?

Nido Biosciences has raised $86.6M across 1 round on record. The most recent is a Series B of $86.6M announced in May 2023.

When did Nido Biosciences last raise funding?

Nido Biosciences' most recent funding round on record is a Series B of $86.6M, announced in May 2023.

Who founded Nido Biosciences?

FundedIQ lists Mike Clayman (Founder) at Nido Biosciences.

Where is Nido Biosciences headquartered?

Nido Biosciences is based in Boston, Massachusetts, United States.

How many employees does Nido Biosciences have?

Nido Biosciences is in the 11-50 employee band.

How does Nido Biosciences' funding compare to other Biotechnology startups?

Nido Biosciences' latest round of $86.6M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Nido Biosciences Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Nido Biosciences is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.